Plus Therapeutics (PSTV) Revenue (2011 - 2026)
Plus Therapeutics (PSTV) reported Revenue of $1.0 million for Q1 2026, down 2.93% year-over-year from $1.1 million in Q1 2025, and down 24.8% quarter-over-quarter from $1.4 million in Q4 2025.
Plus Therapeutics (PSTV) Revenue (2011 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has 14 years of Revenue data on file, last reported at $1.0 million in Q1 2026.
- Revenue for Q1 2026 came in at $1.0 million, down 2.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.2 million (changed 0.46% YoY), and the FY2025 annual result was $5.2 million, down 10.49% from the prior year.
- Revenue eased to $1.0 million in Q1 2026 per PSTV's latest filing, from $1.4 million in the prior quarter.
- Over five years, Revenue peaked at $4.4 million in Q3 2023 and troughed at $73000.0 in Q3 2022.
- A 5-year average of $1.4 million and a median of $1.4 million in 2025 frame the typical range for Revenue.
- The sharpest annual moves came in 2023 and 2024: Revenue surged 5927.4% in 2023, then slumped 66.91% in 2024.
- A 5-year view of Revenue shows it stood at $127000.0 in 2022, then jumped by 933.86% to $1.3 million in 2023, then climbed by 7.54% to $1.4 million in 2024, then dropped by 3.19% to $1.4 million in 2025, then retreated by 24.8% to $1.0 million in 2026.
- Business Quant data shows PSTV's Revenue at $1.0 million in Q1 2026, $1.4 million in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Plus Therapeutics | 37.48 Mn | 22.37 Mn | - | 1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.03 Mn |
| Dec 31, 2025 | 1.37 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 1.39 Mn |
| Mar 31, 2025 | 1.06 Mn |
| Dec 31, 2024 | 1.41 Mn |
| Sep 30, 2024 | 1.46 Mn |
| Jun 30, 2024 | 1.28 Mn |
| Mar 31, 2024 | 1.68 Mn |
| Dec 31, 2023 | 1.31 Mn |
| Sep 30, 2023 | 4.40 Mn |
| Jun 30, 2023 | 1.85 Mn |
| Mar 31, 2023 | 500,000.00 |
| Dec 31, 2022 | 127,000.00 |
| Sep 30, 2022 | 73,000.00 |
| Mar 31, 2019 | 703,000.00 |
| Dec 31, 2018 | 1.42 Mn |
| Sep 30, 2018 | 858,000.00 |
| Jun 30, 2018 | 660,000.00 |
| Mar 31, 2018 | 731,000.00 |